Sun Pharma and Torrent Pharma stand out among large-cap stocks due to their excellent financial health, both earning a perfect Piotroski score of 9. Notably, Sun Pharma's success stems from its robust R&D efforts and global reach, while Torrent Pharma dominates in the Indian and Brazilian markets through growth and strategic acquisitions.

Despite the broader market sell-off, Lupin, Sun Pharma, Torrent Pharma, CCL Products, and Karnataka Bank show remarkable resilience due to robust fundamentals like steady growth, strong pipelines, and strategic moves. Their performance suggests a potential for long-term leadership.

Torrent Pharma has transferred 50,000 UNM Foundation shares worth ₹5 million to its promoter entity, Torrent Investments, in an arms-length transaction.